羟氯喹的全球市场:各适应症，各流通管道，各地区-规模，占有率，展望，机会分析(2022年～2028年)

为了评估羟氯喹对冠状病毒感染疾病患者的治疗的有效性，主要企业增加联盟和共同研究等无机成长策略，预期促进在预测期间内的羟氯喹市场成长。

本报告提供全球羟氯喹市场的相关调查，市场展望，市场动态，市场分析，竞争情形等全面性资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

• 报告的说明
  • 市场定义和范围
• 摘要整理
  • 市场明细:各适应症
  • 市场明细:各流通管道
  • 市场明细:各地区
• Coherent Opportunity Map(COM)

第3章 市场动态，法规，及趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 法规情境
• 产业趋势
• 合併和收购
• 新的疾病适应症的认证/销售
• 推销及行销举措
• PEST分析

第1章 全球羟氯喹市场:各适应症(100万美元)(2017年～2028年)

• 简介
• 疟疾
• 冠状病毒病
• 红斑
• 类风湿性关节炎

第2章 全球羟氯喹市场:各流通管道(100万美元)(2017年～2028年)

• 简介
• 医院药局
• 零售药局
• 线上药局

第3章 全球羟氯喹市场:各地区(100万美元)(2017年～2028年)

• 简介
• 北美
• 南美
• 欧洲
• 亚太地区
• 中东
• 非洲

第4章 竞争情形

• 热图分析
• 市场占有率分析
  • Sanofi SA
  • 适应症组合
  • Amneal Pharmaceuticals, Inc.
  • 适应症组合
  • Laurus Labs Limited
  • 适应症组合
  • Zydus Pharmaceuticals, Inc.
  • 适应症组合
  • Prasco Laboratories
  • 适应症组合
  • Dr. Reddy's Laboratories
  • 适应症组合
  • Cadila Pharmaceuticals
  • 适应症组合
  • Novartis International AG
  • 适应症组合
  • Concordia Pharmaceuticals Inc.
  • 适应症组合
  • Covis Pharmaceuticals, Inc.
  • 适应症组合
  • Cardinal Health
  • 适应症组合
  • Aphena Pharma Solutions Tennessee, Inc.
  • 适应症组合
  • Mylan NV
  • 适应症组合
  • McKesson Corporation
  • 适应症组合
  • Teva Pharmaceutical Industries Ltd
  • 适应症组合
  • Lupin Pharmaceutical
  • 适应症组合
  • Sun Pharmaceutical Industries Ltd
  • 适应症组合
• 分析师的见解

第5章 Section

Hydroxychlorquine has exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to determine its efficacy for the treatment of novel coronavirus disease (COVID 19). According to the studies conducted in Wuhan, the body temperature recovery time and the cough remission time of coronavirus patients were significantly reduced with hydroxycloroquine and chloroquine treatment.

Despite the absence of strong evidence, the demand for hydroxychloroquine has spiked due to the coronavirus (COVID 19) outbreak. However, the doses of hydroxychloroquine need to be monitored, as its overdose can have dangerous side effects such as drowsiness, visual disturbances, cardiovascular collapse, convulsions, hypokalemia, rhythm, ventricular tachycardia, and ventricular fibrillation. This may lead to sudden respiratory and cardiac arrest, which can be fatal.

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to evaluate the efficacy of hydroxchloroquine tablets for the treatment of patients with coronavirus disease (COVID 19) are expected to propel the market growth over the forecast period. For instance, on March 27, 2022, Rising Pharma Holdings Inc., a pharmaceutical company, entered into a collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease, to explore hydroxchloroquine as preventive treatment for coronavirus disease (COVID 19).

Key features of the study:

• This report provides in-depth analysis of the global hydroxchloroquine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hydroxchloroquine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, disease indication up-gradation, market expansion, and marketing tactics
• The global hydroxchloroquine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydroxchloroquine market

Detailed Segmentation:

• Global Hydroxchloroquine Market, By Disease Indication:
  • Malaria
  • Coronavirus disease (COVID 19)
  • Lupus Erythematosus
  • Rheumatoid Arthritis
• Global Hydroxchloroquine Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Hydroxchloroquine Market, By Region:
  • North America
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Disease Indication:
    • Malaria
    • Coronavirus disease (COVID 19)
    • Lupus Erythematosus
    • Rheumatoid Arthritis
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Sanofi S.A.*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Amneal Pharmaceuticals, Inc.
  • Laurus Labs Limited
  • Zydus Pharmaceuticals, Inc.
  • Prasco Laboratories
  • Dr. Reddy's Laboratories
  • Cadila Pharmaceuticals
  • Novartis International AG
  • Concordia Pharmaceuticals Inc.
  • Covis Pharmaceuticals, Inc.
  • Cardinal Health
  • Aphena Pharma Solutions Tennessee, Inc.
  • Mylan N.V.
  • McKesson Corporation
  • Teva Pharmaceutical Industries Ltd
  • Lupin Pharmaceutical
  • Sun Pharmaceutical Industries Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Disease Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• Industry Trend
• Merger and Acquisitions
• New Disease Indication Approvals/Launch
• Promotion and Marketing Initiatives
• PEST Analysis

1. Global Hydroxychloroquine Market, By Disease Indication, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Malaria
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Coronavirus Disease (COVID 19)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Lupus Erythematosus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Rheumatoid Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

2. Global Hydroxychloroquine Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

3. Global Hydroxychloroquine Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

4. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Sanofi S.A.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Amneal Pharmaceuticals, Inc.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Laurus Labs Limited
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Zydus Pharmaceuticals, Inc.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Prasco Laboratories
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dr. Reddy's Laboratories
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Cadila Pharmaceuticals
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novartis International AG
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Concordia Pharmaceuticals Inc.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Covis Pharmaceuticals, Inc.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Cardinal Health
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aphena Pharma Solutions Tennessee, Inc.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mylan N.V.
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • McKesson Corporation
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lupin Pharmaceutical
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd
  • Company Overview
  • Disease Indication Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Analyst Views

5. Section

• References
• Research Methodology
• About us and Sales Contact